Cubist Systematic Strategies’s scPharmaceuticals SCPH Stock Holding History

Cubist Systematic Strategies’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$150K	Buy	+26,532	New	+$136K	﹤0.01%	2715
2025 Q2	–	Sell	-28,759	Closed	-$75.6K	–	3456
2025 Q1	$75.6K	Buy	+28,759	New	+$93.7K	﹤0.01%	2665
2023 Q2	–	Sell	-91,453	Closed	-$829K	–	4214
2023 Q1	$829K	Buy	91,453 +39,661	+77%	+$291K	0.01%	2328
2022 Q4	$371K	Buy	51,792 +40,219	+348%	+$246K	﹤0.01%	3223
2022 Q3	$75K	Buy	+11,573	New	+$61.8K	﹤0.01%	4070

Other funds holding SCPH

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Cubist Systematic Strategies's SCPH Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in scPharmaceuticals (SCPH) in Q3 2025: 26,532 shares worth $150K. The stake represents ﹤0.01% of the portfolio and ranks #2715 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in SCPH as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in SCPH in Q3 2022 and has held it in 5 quarters since. The position peaked at $829K in Q1 2023. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

Cubist Systematic Strategies held 26,532 shares of scPharmaceuticals worth $150K as of Q3 2025.
scPharmaceuticals was a new Cubist Systematic Strategies position in Q3 2025.
scPharmaceuticals made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2715 holding.
Cubist Systematic Strategies first reported a position in scPharmaceuticals in Q3 2022 and has held it in 5 quarters since.
Cubist Systematic Strategies's scPharmaceuticals position peaked at $829K in Q1 2023.
110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.